KPV

KPV is a three-amino-acid peptide—lysine, proline, and valine—derived from the C-terminal portion of alpha-melanocyte-stimulating hormone. It is researched primarily for anti-inflammatory and immune-signaling effects without the pigment-related activity associated with the full alpha-MSH molecule. In experimental research, KPV has been shown to reduce inflammatory signaling such as NF-kB activation and pro-inflammatory cytokine release in intestinal cells, and it has also been studied in animal models of colitis study. At Bowery Clinic, KPV is available as a clinician-guided wellness option for patients interested in inflammation and gut-support pathways.

KPV appears to work by modulating inflammatory signaling rather than by acting as a stimulant, hormone, or appetite suppressant. Research has shown that KPV can enter intestinal and immune cells through peptide transport mechanisms and reduce NF-kB/MAPK signaling and inflammatory cytokine production research. That makes KPV relevant to wellness conversations involving gut comfort, inflammatory balance, and tissue resilience. It should not be marketed as a proven cure for inflammatory bowel disease, autoimmune disease, or another diagnosed condition.

KPV’s human safety profile is not as extensively characterized as that of conventional anti-inflammatory medications, so clinician screening is necessary, and KPV should not be considered universally safe. Important considerations include active medical conditions, pregnancy, allergies, other medications, and whether a patient is already using multiple compounded peptides. Because Bowery offers KPV as a troche, local mouth irritation or taste-related issues are possible in addition to any systemic reaction. Patients should report new gastrointestinal symptoms, rash, swelling, dizziness, or other unexpected changes.

KPV is usually evaluated over about 2–4 weeks for comfort and inflammation-related wellness goals. Some patients may notice a change within the first 1–2 weeks, but there is no established human onset time for KPV. If there is no meaningful improvement by the end of the planned cycle, the protocol should be reassessed.

Bowery Clinic peptides are higher-strength and clinically dosed compared to most research facilities that use much lower concentrations. They are compounded by licensed 503A pharmacies with physician oversight and sterile quality standards, prioritizing real therapeutic outcomes over cheaper, unregulated research-grade products, and come fully prepared and ready for use — no mixing or reconstitution needed.

Yes. All pharmacies in our network are fully licensed in the states where they operate and comply with all state board of pharmacy regulations. Unlike many peptide clinics, we partner exclusively with FDA-registered U.S. pharmacies that undergo rigorous evaluation and compliance checks.

Every patient receives treatment plans developed and monitored by licensed providers. This includes safe titration of dosages and ongoing medical oversight tailored to individual needs.

Injections deliver the medication directly into your system. This makes the absorption more consistent and effective. Troches are small dissolvable lozenges that sit in your mouth until they melt, slowly releasing medication through the lining of your cheek or under your tongue.